Carbamate compounds and methods of making and using same
US-2018208568-A1 · Jul 26, 2018 · US
Carbamate compounds and methods of making and using same
US11021453B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11021453-B2 |
| Application number | US-201916717813-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 17, 2019 |
| Priority date | Jan 6, 2012 |
| Publication date | Jun 1, 2021 |
| Grant date | Jun 1, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for a method of treating a patient in need thereof, where the patient is suffering from post-traumatic stress disorder comprising administering a disclosed compound or composition.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating post-traumatic stress disorder in a patient in need thereof, comprising administering to the patient an effective amount of 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
Anxiolytics · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
linked by a carbon chain containing aromatic rings · CPC title
Benzopyrazoles; Hydrogenated benzopyrazoles · CPC title
Spiro-condensed systems · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11021453B2 cover?
- This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for a method of treating a patient in need thereof, where the patient is suffering from post-traumatic stres…
- Who is the assignee on this patent?
- Lundbeck La Jolla Research Center Inc, Scripps Research Inst
- What technology area does this patent fall under?
- Primary CPC classification C07D295/205. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).